You are here

Article Text

Article menu
Download PDFPDF
Research paper
Novel TOR1A mutation p.Arg288Gln in early-onset dystonia (DYT1)
  1. B Zirn1,
  2. K Grundmann2,
  3. P Huppke3,
  4. J Puthenparampil2,
  5. H Wolburg4,
  6. O Riess2,
  7. U Müller1
  1. 1
    Institute of Human Genetics, University of Giessen, Germany
  2. 2
    Institute of Medical Genetics, University of Tuebingen, Germany
  3. 3
    Department of Neuropediatrics, University of Goettingen, Germany
  4. 4
    Department of Pathology, University of Tuebingen, Germany
  1. Professor Ulrich Müller, Institute of Human Genetics, Schlangenzahl 14, D-35392 Giessen, Germany; Ulrich.Mueller{at}humangenetik.med.uni-giessen.de

Abstract

Background: The three-nucleotide deletion, GAG (within the gene TOR1A), is the only proven cause of childhood-onset dystonia (DYT1). A potentially pathogenic role of additional sequence changes within TOR1A has not been conclusively shown.

Methods: DNA sequencing of exon 5 of TOR1A in a patient with DYT1.

Results: Detection of sequence change c.863G>A in exon 5 of TOR1A in the patient. The G>A transition results in an exchange of an arginine for glutamine (p.Arg288Gln) in subdomain α5 of TOR1A. Several findings point to a potentially pathogenic role of the sequence change in the patient: The base change is absent in 1000 control chromosomes; an Arg at position 288 of TOR1A has been conserved throughout vertebrate evolution, indicating an important role of Arg288 in TOR1A function; functional studies demonstrate enlarged perinuclear space in HEK293 cells overexpressing TOR1A with the p.Arg288Gln mutation. The same morphological changes are observed in cells overexpressing the common GAG TOR1A mutation but not in cells overexpressing wild-type TOR1A.

Conclusions: The sequence change described here may be a novel pathogenic mutation of TOR1A in DYT1.

https://doi.org/10.1136/jnnp.2008.148270

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Competing interests: None.